REOPRO®

(Abciximab)

Documentation

Patented
Approved 1997
FDA Letter
FDA Label
Full Sequence

Brief Summary

Function Type: Antagonist
Target: CD41(Integrin-α2β)
Indication Category: Other

Approved Indications

Detailed Summary

Side Effects

References

Wikipedia
Drugs.com
FDA